Aristotle Capital Boston LLC Has $8.54 Million Stake in Acadia Healthcare Company, Inc. $ACHC

Aristotle Capital Boston LLC trimmed its position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 9.3% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 601,654 shares of the company’s stock after selling 61,999 shares during the quarter. Aristotle Capital Boston LLC owned 0.65% of Acadia Healthcare worth $8,537,000 at the end of the most recent reporting period.

A number of other institutional investors also recently modified their holdings of ACHC. EverSource Wealth Advisors LLC raised its position in shares of Acadia Healthcare by 54.8% during the second quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock worth $32,000 after purchasing an additional 497 shares during the period. Wells Fargo & Company MN raised its position in shares of Acadia Healthcare by 208.9% during the fourth quarter. Wells Fargo & Company MN now owns 2,233 shares of the company’s stock worth $32,000 after purchasing an additional 1,510 shares during the period. Bayforest Capital Ltd bought a new stake in Acadia Healthcare during the fourth quarter worth $52,000. GAMMA Investing LLC grew its holdings in Acadia Healthcare by 124.7% during the fourth quarter. GAMMA Investing LLC now owns 4,862 shares of the company’s stock worth $69,000 after buying an additional 2,698 shares in the last quarter. Finally, Praxis Investment Management Inc. bought a new stake in Acadia Healthcare during the fourth quarter worth $170,000.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on ACHC. Zacks Research upgraded Acadia Healthcare from a “strong sell” rating to a “hold” rating in a report on Thursday, March 5th. Leerink Partners upped their price target on Acadia Healthcare from $14.00 to $22.00 and gave the stock a “market perform” rating in a report on Thursday, February 26th. KeyCorp reiterated an “overweight” rating and set a $30.00 price target on shares of Acadia Healthcare in a report on Wednesday, May 27th. Barclays upped their price target on Acadia Healthcare from $20.00 to $25.00 and gave the stock an “equal weight” rating in a report on Thursday, April 30th. Finally, Cantor Fitzgerald boosted their price objective on Acadia Healthcare from $20.00 to $30.00 and gave the stock a “neutral” rating in a research report on Friday, May 1st. One research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, five have assigned a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $26.85.

Acadia Healthcare Stock Down 6.0%

Shares of NASDAQ ACHC opened at $23.50 on Thursday. Acadia Healthcare Company, Inc. has a one year low of $11.43 and a one year high of $30.20. The company has a debt-to-equity ratio of 1.27, a current ratio of 1.71 and a quick ratio of 1.71. The business’s fifty day moving average price is $25.53 and its 200-day moving average price is $20.23. The stock has a market capitalization of $2.16 billion, a PE ratio of -1.92, a P/E/G ratio of 8.34 and a beta of 0.69.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings results on Wednesday, April 29th. The company reported $0.37 EPS for the quarter, beating analysts’ consensus estimates of $0.28 by $0.09. Acadia Healthcare had a positive return on equity of 7.09% and a negative net margin of 32.84%.The firm had revenue of $828.80 million for the quarter, compared to analysts’ expectations of $823.51 million. During the same quarter in the prior year, the firm earned $0.40 EPS. The business’s revenue for the quarter was up 7.6% compared to the same quarter last year. Acadia Healthcare has set its Q2 2026 guidance at 0.300-0.400 EPS. On average, equities research analysts anticipate that Acadia Healthcare Company, Inc. will post 1.5 EPS for the current year.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.